SCI Abstract

search
Mifepristone as Bridge or Adjunct Therapy in the Management of Challenging Cushing Disease Cases
Mifepristone as Bridge or Adjunct Therapy in the Management of Challenging Cushing Disease Cases
Establishing a definitive diagnosis of Cushing disease (CD), given its clinical and biochemical heterogeneity, initiating ...
Dyslipidemia Increases the Risk of Severe COVID-19: A Systematic Review, Meta-analysis, and Meta-regression
Dyslipidemia Increases the Risk of Severe COVID-19: A Systematic Review, Meta-analysis, and Meta-regression
Objective:This systematic review and meta-analysis aimed to evaluate whether dyslipidemia affects the mortality and severi...
Therapeutic Potential of Peptides Derived from Animal Venoms: Current Views and Emerging Drugs for Diabetes
Therapeutic Potential of Peptides Derived from Animal Venoms: Current Views and Emerging Drugs for Diabetes
The therapeutic potential of venom-derived drugs is evident today. Currently, several significant drugs are FDA approved f...
Search for Genetic Predictors of Adult Autoimmune Polyendocrine Syndrome in Monozygotic Twins
Search for Genetic Predictors of Adult Autoimmune Polyendocrine Syndrome in Monozygotic Twins
Autoimmune polyendocrine syndromes (APS) are a heterogeneous group of diseases characterized by the presence of autoimmune...
Glycemic Variability in Type 1 Diabetes Mellitus Saudis Using Ambulatory Glucose Profile
Glycemic Variability in Type 1 Diabetes Mellitus Saudis Using Ambulatory Glucose Profile
Background:Glucose variability (GV) is a common and challenging clinical entity in the management of people with type 1 di...
Pleiotropic Benefits of DPP-4 Inhibitors Beyond Glycemic Control
Pleiotropic Benefits of DPP-4 Inhibitors Beyond Glycemic Control
Dipeptidyl peptidase (DPP)-4 inhibitors are oral anti-diabetic medications that block the activity of the ubiquitous enzym...
Role of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in Hypoglycemia
Role of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in Hypoglycemia
A relatively recent addition to the arsenal of antidiabetic drugs used for the treatment of type 2 diabetes mellitus (T2DM...
Xenin and Related Peptides: Potential Therapeutic Role in Diabetes and Related Metabolic Disorders
Xenin and Related Peptides: Potential Therapeutic Role in Diabetes and Related Metabolic Disorders
Xenin bioactivity and its role in normal physiology has been investigated by several research groups since its discovery i...
A Review of Coumarins and Coumarin-Related Compounds for Their Potential Antidiabetic Effect
A Review of Coumarins and Coumarin-Related Compounds for Their Potential Antidiabetic Effect
Background and aims:Worldwide, type 2 diabetes mellitus accounts for a considerable burden of disease, with an estimated g...
Sedentary Behavior Counseling Intervention in Aging People With Type 2 Diabetes: A Feasibility Study
Sedentary Behavior Counseling Intervention in Aging People With Type 2 Diabetes: A Feasibility Study
This study examined the feasibility and effect of sedentary behavior (SB) counseling on total sitting time (TST) and glyce...
Associations Between Glucose Tolerance, Insulin Secretion, Muscle and Fat Mass in Cystic Fibrosis
Associations Between Glucose Tolerance, Insulin Secretion, Muscle and Fat Mass in Cystic Fibrosis
Background:A frequent comorbidity in cystic fibrosis (CF) is CF related diabetes (CFRD) caused by a gradual decline in ins...
Islet Function in the Pathogenesis of Cystic Fibrosis-Related Diabetes Mellitus
Islet Function in the Pathogenesis of Cystic Fibrosis-Related Diabetes Mellitus
Cystic fibrosis-related diabetes mellitus (CFRD) is the most common non-pulmonary co-morbidity in cystic fibrosis (CF). CF...